3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Intraepithelial Lesions
1
Papillomavirus Infections
1
Mucositis
1
Hematologic Neoplasms
1
HIV Infections
1
Gallbladder Neoplasms
1
Breast Carcinoma In Situ
1
Bile Duct Neoplasms
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Doxorubicin
6
Vincristine
4
Liposomes
4
Bleomycin
4
Fluorouracil
3
Watchful Waiting
2
Light Coagulation
2
Imiquimod
2
sargramostim
1
Zidovudine
1
Vaccines
1
Sodium Chloride
1
Papillomavirus Vaccines
1
Observation
1
Methotrexate
1
Leucovorin
1
Laser Therapy
1
Isotretinoin
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Fluconazole
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Cyclophosphamide
1
Circumcision, Male
1
Amphotericin B
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
HIV Infections
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts